25th Jun 2021 17:25
Renalytix plc
("Renalytix" or the "Company")
Director/PDMR Dealing
The Company was informed that today, Fergus Fleming, Chief Technology Officer, completed the sale of 15,000 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company at a price of 1075 pence per share.
Following completion of the sale, Fergus Fleming is interested in 569,481 Ordinary Shares representing 0.79% of the current issued share capital of the Company.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
|
Fergus Fleming | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Chief Technology Officer | |||
b)
| Initial notification /Amendment
| Initial Notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Renalytix plc | |||
b)
| LEI
| 213800NTOH3FK3WER551 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of £0.0025 each | |||
Identification code | GB00BYWL4Y04
| ||||
| |||||
b)
| Nature of the transaction
| Sale of shares | |||
c) | Currency | GBP | |||
d)
| Price(s) and volume(s) |
|
|
|
|
| Price(s) | Volume(s) |
| ||
| £10.75 | 15,000 |
| ||
|
|
|
| ||
e)
| Aggregated information | ||||
- Aggregated volume | 15,000 | ||||
- Price | £161,250.00 | ||||
f)
| Date of the transaction
| 25 June 2021 | |||
g)
| Place of the transaction
| London Stock Exchange | |||
Related Shares:
Renalytix Plc